Q2

Onesource Specialty Pharma Ltd

ONESOURCEFY2611 Nov 2025

Revenue+14.8%

Net Profit+5737.1%

OPM28.34%

P&L

Quarterly Consolidated

Revenue

+14.8%375.76

Expenditure

+11.7%373.06

Net Profit

+5737.1%10.48

NPM 2.77%+4716.7%EPS ₹0.92+4500.0%

vs Q1 FY26

Informational and educational content only. Not investment advice.